Stock Information
United Therapeutics Corp (UTHR)
Ticker Symbol: UTHR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $24,318.80 mil
Piotroski score: 5
PE Ratio: 18.5467
EPS (TTM): 27.9001
Revenue (TTM): $67.29 M
Dividend Yield: N/A%
ROE: 19.3%
Latest News
-
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
Fri, Apr 3, 2026 4:10 PM
-
CPRX or UTHR: Which Is the Better Value Stock Right Now?
Fri, Apr 3, 2026 3:40 PM
-
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate
Thu, Apr 2, 2026 10:13 AM
-
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win
Wed, Apr 1, 2026 3:38 PM
-
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Wed, Apr 1, 2026 1:00 PM
-
United Therapeutics (UTHR) Is Up 11.5% After Positive IPF Phase 3 Tyvaso Data Met Key Endpoint
Tue, Mar 31, 2026 10:08 PM
-
UTHR Stock Rises 12.5% on Promising Data From TETON-1 Tyvaso Study
Tue, Mar 31, 2026 4:05 PM
-
Assessing United Therapeutics (UTHR) Valuation After Positive Tyvaso Phase 3 IPF Trial Results
Tue, Mar 31, 2026 2:07 PM
-
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo
Tue, Mar 31, 2026 1:13 PM
-
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Tue, Mar 31, 2026 1:00 PM
Key Financials
Financial data not available
